资讯 Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmis 2026-02-02
资讯 Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficien 2026-02-02
